Vivani Medical, Inc. (VANI)
Nasdaq: VANI · Electromedical & Electrotherapeutic Apparatus · Alameda, CA · filing with the SEC since 2003
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Report filed | Mar 26, 2026 | Mar 31, 2025 | Mar 26, 2024 | Mar 31, 2023 | Mar 29, 2022 | Mar 16, 2021 | Mar 19, 2020 | Mar 19, 2019 | Mar 20, 2018 | Mar 16, 2017 |
| Revenue | 0 | 0 | · | · | · | · | 3,379 | 6,896 | 7,964 | 3,985 |
| For lenders | ||||||||||
| Interest and dividend income | · | · | · | 475 | 550r | 16 | 362 | 86 | 93 | 31 |
| Cost of revenue | · | · | · | · | 130 | 500 | 2,152 | 4,888 | 5,117 | 10,076 |
| Gross profit | · | · | · | · | 130 | 500 | 1,227 | 2,008 | 2,847 | -6,091 |
| Research and development | 18,126 | 15,745 | 16,968 | 14,169 | 11,002r | 4,836 | 13,143 | 10,005 | 7,893 | 5,347 |
| Sales and marketing | · | · | · | · | · | 701 | 6,101 | 11,336 | 9,569 | 8,989 |
| General and administrative | 9,430 | 8,932 | 9,997 | 7,072 | 2,321r | 5,943 | 9,226 | 10,692 | 10,932 | 10,080 |
| Total operating expenses | 27,556 | 24,677 | 26,965 | 21,241 | 13,323r | 15,396 | 35,181 | 37,188 | 31,456 | 27,119 |
| Operating income | -27,556 | -24,677 | -26,965 | -21,241 | -13,323r | -14,896 | -33,954 | -35,180 | -28,609 | -33,210 |
| Other income (expense), net | 947 | 1,191 | 1,313 | · | · | · | · | · | · | · |
| Income before income taxes | -26,609 | -23,487 | · | · | · | · | · | · | · | · |
| Income tax expense | · | 2 | · | · | · | · | 0 | 0 | · | · |
| Net income | -26,609 | -23,486 | -25,652 | -13,889 | -12,773r | -14,880 | -33,592 | -35,094 | -28,516 | -33,179 |
| Earnings per share, basic | -0.43 | -0.43 | -0.50 | · | · | · | · | · | · | · |
| Earnings per share, diluted | -0.43 | -0.43 | -0.50 | · | · | · | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -0.27 | -0.72 | -2.28 | -4.23r | -0.53 | -0.84 |
| Weighted average shares, basic | 62,389,000 | 54,981,000r | 50,853 | · | · | · | · | · | · | · |
| Weighted average shares, diluted | 62,389,000 | 54,981,000r | 50,853,000b | · | · | · | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 32,817,000 | 20,575,000 | 14,708,000 | 8,297,000r | 54,152,000 | 39,554,000r |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:SalesRevenueGoodsNetInterest and dividend income what its loans and securities earned
us-gaap:InterestIncomeOperatingCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSales and marketing the cost of finding and serving customers
us-gaap:SellingAndMarketingExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstandingWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted